Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gigantum is a technology company that provides an open-source platform designed to enhance the transparency, reproducibility, and collaboration of data science and scientific research. The platform automates the versioning of code, data, and software environments, allowing researchers to create "Project" containers that can be easily shared and executed across different computing infrastructures. This technology is particularly valuable in the life sciences and biotech sectors, where managing complex datasets and ensuring the auditability of computational results are critical. In 2022, Gigantum was acquired by NVIDIA to integrate its versioning and collaboration capabilities into NVIDIA's suite of tools for data scientists and researchers. The company was originally founded by a team of researchers from the Johns Hopkins University Applied Physics Laboratory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gigantum.